Levonorgestrel
- Generic Name
- Levonorgestrel
- Brand Names
- Afirmelle 28 Day, Aftera, Alesse, Altavera 28 Day, Amethia 91 Day, Amethyst, Ashlyna 91 Day, Aubra 28 Day, Aviane 28, Ayuna 28 Day Pack, Balcoltra 28 Day, Bionafem, Camrese 91 Day, Camreselo 91 Day, Chateal 28 Day, Climara Pro, Curae, Daysee 91 Day, Delyla 28 Day, Dolishale 28 Day, Econtra, Enpresse 28 Day, Fallback Solo, Falmina 28 Day, Fayosim 91 Day, Her Style, Iclevia 91 Day, Indayo, Introvale 91 Day, Jaimiess 91 Day, Jolessa 91 Day, Joyeaux 28 Day, Kurvelo, Kyleena, Larissia 28 Day Pack, Levonest 28 Day, Levora 0.15/30 28 Day, Liletta, Lillow 28 Day, Lo Simpesse, LoJaimiess, Loseasonique, Lutera 28 Day, Marlissa 28 Day, Min-ovral, Mirena, Morning After, My Choice, My Way, Myzilra 28 Day, New Day, Next Choice, Next Choice One Dose, Opcicon One-step, Option 2, Orsythia 28 Day, Plan B, Plan B One-step, Portia 28 Day, Preventeza, Quartette 91 Day Pack, React, Rivelsa 91 Day, Seasonale, Seasonique, Setlakin 91 Day, Simpesse, Skyla, Sronyx 28 Day, Take Action, Triquilar, Trivora 28 Day, Twirla 3 Count Weekly Patch, Tyblume 28 Day, Vienva 28 Day
- Drug Type
- Small Molecule
- Chemical Formula
- C21H28O2
- CAS Number
- 797-63-7
- Unique Ingredient Identifier
- 5W7SIA7YZW
- Background
Levonorgestrel (LNG) is a synthetic progestogen similar to Progesterone used in contraception and hormone therapy. Also known as Plan B, it is used as a single agent in emergency contraception, and as a hormonal contraceptive released from an intrauterine device, commonly referred to as an IUD. Some of these devices are known as Jaydess, Kyleena, and Mirena....
- Indication
Emergency contraception
...
- Associated Conditions
- Endometrial Hyperplasia, Endometriosis, Heavy Menstrual Bleeding, Hypermenorrhea, Postmenopausal Osteoporosis, Pregnancy, Moderate Menopausal Vasomotor Symptoms, Severe Vasomotor Symptoms Associated With Menopause
- Associated Therapies
- Emergency Contraception
Big Post-Election Surge Seen in Online Sales of Morning-After Pills
Post-election, online sales of emergency contraceptives surged, with women stockpiling due to concerns over potential access restrictions under the new administration.
Biden Administration's New Family Planning Rule: What It Would Mean for Public Health
The Biden Administration proposes a regulation requiring health plans to cover over-the-counter contraception without copays, expanding reproductive health access post-_Dobbs v. Jackson_. This rule, under the Affordable Care Act, includes FDA-approved contraceptives like oral pills, patches, rings, and emergency contraception, accessible without prescriptions or copays. The proposal aims to remove financial barriers, improving access for millions, especially women facing cost-related challenges, and enhancing public health outcomes.
The Future of Rare Disease Treatment with Precision Medicine
Rare diseases affect 7% of the world’s population, mostly genetic. Precision medicine offers tailored treatments, overcoming traditional pharmaceutical research limitations. Success stories include therapies for spinal muscle atrophy, Batten’s disease, Duchenne muscular dystrophy, and cystic fibrosis. Challenges remain in cost, ethical considerations, and data sharing, but advancements in genomic sequencing, AI, and digital technology hold promise.
Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure
Kerendia, a nonsteroidal mineralocorticoid receptor antagonist, reduced cardiovascular death risk by 16% in HF patients with ejection fraction >40% in a phase 3 trial. Hyperkalemia incidence was higher but not significant, with no hospitalizations or deaths.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath